Intracerebroventricular Shiga toxin 2 increases the expression of its receptor globotriaosylceramide and causes dendritic abnormalities

Journal of Neuroimmunology

Volumn 222, Issue 1-2, 2010, Pages 48-61

  Tironi Farinati, Carla ^a   Loidl, C Fabián ^a   Boccoli, Javier ^a   Parma, Yanil ^b   Fernandez Miyakawa, Mariano E ^b   Goldstein, Jorge ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

Author keywords

Gb3; GFAP; Intracerebroventricular; MAP2; Neuronal damage; Shiga toxin 2

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; GLOBOTRIAOSYLCERAMIDE; MICROTUBULE ASSOCIATED PROTEIN 2; PROTEIN BAX; VEROTOXIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BODY WEIGHT; BRAIN CORTEX; BRAIN NERVE CELL; CELL POPULATION; CONTROLLED STUDY; CORPUS STRIATUM; DENDRITE; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; HUMAN CELL; HYPOTHALAMUS; IMMUNODETECTION; IMMUNOFLUORESCENCE; MALE; MOTOR DYSFUNCTION; NERVE CELL LESION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BIOLOGICAL MARKERS; BRAIN; CERCOPITHECUS AETHIOPS; DENDRITES; ESCHERICHIA COLI INFECTIONS; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENTRICULAR; MALE; MICROSCOPY, CONFOCAL; MICROTUBULE-ASSOCIATED PROTEINS; NERVE DEGENERATION; NEUROTOXICITY SYNDROMES; RATS; RATS, SPRAGUE-DAWLEY; SHIGA TOXIN 2; TRIHEXOSYLCERAMIDES; UP-REGULATION; VERO CELLS;

EID: 77952290131     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.03.001     Document Type: Article

References (59)

1. Barnett N.D.P., Kaplan A.M., Bernes S.M., Cohen M.L. Hemolytic uremic syndrome with particular involvement of basal ganglia and favorable outcome. Pediatr. Neurol. 1995, 12:155-158.
2. Bidmon H.J., Jancsik V., Schleicher A., Hagemann G., Witte O.W., Woodhams P., Zilles K. Structural alterations and changes in cytoskeletal proteins and proteoglycans after focal cortical ischemia. Neuroscience 1998, 82:397-420.
3. Boccoli J., Loidl C.F., Lopez-Costa J.J., Creydt V.P., Ibarra C., Goldstein J. Intracerebroventricular administration of Shiga toxin type 2 altered the expression levels of neuronal nitric oxide synthase and glial fibrillary acidic protein in rat brains. Brain Res. 2008, 1230:320-333.
4. Bolam J.P., Hanley J.J., Booth P.A., Bevan M.D. Synaptic organisation of the basal ganglia. J. Anat. 2000, 196:527-542.
5. Candiano G., Bruschi M., Musante L., Santucci L., Ghiggeri G.M., Carnemolla B., Orecchia P., Zardi L., Righetti P.G. Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 2004, 25:1327-1333.
6. Cassina P., Pehar M., Vargas M.R., Castellanos R., Barbeito A.G., Estevez A.G., Thompson J.A., Beckman J.S., Barbeito L. Astrocyte activation by fibroblast growth factor-1 and motor neuron apoptosis: implications for amyotrophic lateral sclerosis. J. Neurochem. 2005, 93:38-46.
7. Cotter D., Wilson S., Roberts E., Kerwin R., Everall I.P. Increased dendritic MAP2 expression in the hippocampus in schizophrenia. Schizophr. Res. 2000, 41:313-323.
8. Dupuis L., Pehar M., Cassina P., Rene F., Castellanos R., Rouaux C., Gandelman M., Dimos L., Schwab M.E., Loeffler J.P., Barbeito L., Gonzalez de Aguilar J.L. Nogo receptor antagonizes p75NTR-dependent motor neuron death. Proc. Natl Acad. Sci. USA 2008, 105:740-745.
9. 3 and sensitivity to Shiga toxin. Infect. Immun. 2001, 69:1889-1894.
10. Eriksson K.J., Boyd S.G., Tasker R.C. Acute neurology and neurophysiology of haemolytic-uraemic syndrome. Arch. Dis. Child. 2001, 84:434-435.
11. Faddis B.T., Hasbani M.J., Goldberg M.P. Calpain activation contributes to dendritic remodeling after brief excitotoxic injury in vitro. J. Neurosci. 1997, 17:951-959.
12. Falguieres T., Johannes L. Shiga toxin B-subunit binds to the chaperone BiP and the nucleolar protein B23. Biol. Cell 2006, 98:125-134.
13. Falguières T., Mallard F., Baron C., Hanau D., Lingwood C., Goud B., Salamero J., Johannes L. Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. Mol. Biol. Cell 2001, 12:2453-2468.
14. Fiala J.C., Spacek J., Harris K.M. Dendritic spine pathology: cause or consequence of neurological disorders?. Brain Res. Brain Res. Rev. 2002, 39:29-54.
15. Francis D.H., Moxley R.A., Andraos C.Y. Edema disease-like brain lesions in gnotobiotic piglets infected with Escherichia coli serotype O157:H7. Infect. Immun. 1989, 57:1339-1342.
16. Fujii J., Kita T., Yoshida S., Takeda T., Kobayashi H., Tanaka N., Ohsato K., Mizuguchi Y. Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice. Infect. Immun. 1994, 62:3447-3453.
17. Fujii J., Kinoshita Y., Kita T., Higure A., Takeda T., Tanaka N., Yoshida S. Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2. Infect. Immun. 1996, 64:5053-5060.
18. Fujii J., Kinoshita Y., Yamada Y., Yutsudo T., Kita T., Takeda T., Yoshida S. Neurotoxicity of intrathecal Shiga toxin 2 and protection by intrathecal injection of anti-Shiga toxin 2 antiserum in rabbits. Microb. Pathog. 1998, 25:139-146.
19. Fujii J., Matsui T., Heatherly D.P., Schlegel K.H., Lobo P.I., Yutsudo T., Ciraolo G.M., Morris R.E., Obrig T. Rapid apoptosis induced by Shiga toxin in HeLa cells. Infect. Immun. 2003, 71:2724-2735.
20. Fujii J., Wood K., Matsuda F., Carneiro-Filho B.A., Schlegel K.H., Yutsudo T., Binnington-Boyd B., Lingwood C.A., Obata F., Kim K.S., Yoshida S., Obrig T. Shiga toxin 2 causes apoptosis in human brain microvascular endothelial cells via C/EBP homologous protein. Infect. Immun. 2008, 76:3679-3689.
21. Goldstein J., Loidl C.F., Creydt V.P., Boccoli J., Ibarra C. Intracerebroventricular administration of Shiga toxin type 2 induces striatal neuronal death and glial alterations: an ultrastructural study. Brain Res. 2007, 1161:106-115.
22. Johannes L., Decaudin D. Protein toxins: intracellular trafficking for targeted therapy. Gene Ther. 2005, 16:1360-1368.
23. Johansson D., Johansson A., Grankvist K., Andersson U., Henriksson R., Bergström P., Brännström T., Behnam-Motlagh P. Verotoxin-1 induction of apoptosis in Gb3-expressing human glioma cell lines. Cancer Biol. Ther. 2006, 5:1211-1217.
24. Jones N.L., Islur A., Haq R., Mascarenhas M., Karmali M.A., Perdue M.H., Zanke B.W., Sherman P.M. Escherichia coli Shiga toxins induce apoptosis in epithelial cells that is regulated by the Bcl-2 family. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 278:G811-G819.
25. Karmali M.A. Infection by Shiga toxin-producing Escherichia coli: an overview. Mol. Biotechnol. 2004, 26:117-122.
26. Kato K., Masa T., Tawara Y., Kobayashi K., Oka T., Okabe A., Shiosaka S. Dendritic aberrations in the hippocampal granular layer and the amygdalohippocampal area following kindled-seizures. Brain Res. 2001, 901:281-295.
27. Lechan R.M., Fekete C. The TRH neuron: a hypothalamic integrator of energy metabolism. Prog. Brain Res. 2006, 153:209-235.
28. Lei D.L., Yang D.L., Liu H.M. Local injection of kainic acid causes widespread degeneration of NADPH-d neurons and induction of NADPH-d in neurons, endothelial cells and reactive astrocytes. Brain Res. 1996, 19:199-206.
29. Liu C.L., Siesjo B.K., Hu B.R. Pathogenesis of hippocampal neuronal death after hypoxia-ischemia changes during brain development. Neuroscience 2004, 127:113-123.
30. Liu X., Sullivan K.A., Madl J.E., Legare M., Tjalkens R.B. Manganese-induced neurotoxicity: the role of astroglial-derived nitric oxide in striatal interneuron degeneration. Toxicol. Sci. 2006, 91:521-531.
31. Lord J.M., Roberts L.M., Lencer W.I. Entry of protein toxins into mammalian cells by crossing the endoplasmic reticulum membrane: co-opting basic mechanisms of endoplasmic reticulum-associated degradation. Curr. Top. Microbiol. Immunol. 2005, 300:149-168.
32. Louise C.B., Obrig T.G. Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect. Immun. 1991, 59:4173-4179.
33. Louise C.B., Obrig T.G. Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect. Immun. 1992, 60:1536-1543.
34. Mallard F., Antony C., Tenza D., Salamero J., Goud B., Johannes L. Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of shiga toxin B-fragment transport. J. Cell Biol. 1998, 143:973-990.
35. Mizuguchi M., Tanaka S., Fujii I., Tanizawa H., Suzuki Y., Igarashi T., Yamanaka T., Takeda T., Miwa M. Neuronal and vascular pathology produced by verocytotoxin 2 in the rabbit central nervous system. Acta Neuropathol. 1996, 91:254-262.
36. Obata F., Tohyama K., Bonev A.D., Kolling G.L., Keepers T.R., Gross L.K., Nelson M.T., Sato S., Obrig T.G. Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons. J. Infect. Dis. 2008, 198:1398-1406.
37. O'Brien A.D., Kaper J.B. Shiga toxin-producing Escherichia coli: yesterday, today, and tomorrow. Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains. Am. Soc. Microbiology. Washington, DC 1998, 1-11. J.B. Kaper, A.D. O'Brien (Eds.).
38. Tesh V.L., Samuel J.E., Perera L.P., Sharefkin J.B., O'Brien A.D. Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells. J Infect. Dis. 1991, 164:344-352.
39. Okuda T., Nakayama K. Identification and characterization of the human Gb3/CD77 synthase gene promoter. Glycobiology 2008, 18:1028-1035.
40. Paton J.C., Paton A.W. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin. Microbiol. Rev. 1998, 11:450-479.
41. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2005, Elsevier Academic Press, Burlington, MA, U.S.A. Fifth Edition.
42. Pehar M., Cassina P., Vargas M.R., Castellanos R., Viera L., Beckman J.S., Estevez A.G., Barbeito L. Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis. J. Neurochem. 2004, 89:464-473.
43. Pei Q., Burnet P.J., Zetterström T.S. Changes in mRNA abundance of microtubule-associated proteins in the rat brain following electroconvulsive shock. NeuroReport 1998, 9:391-394.
44. Proulx F., Seidman E.G., Karpman D. Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. Pediatr. Res. 2001, 50:63-171.
45. Psotka M.A., Obata F., Kolling G.L., Gross L.K., Saleem M.A., Satchell S.C., Mathieson P.W., Obrig T.G. Shiga toxin 2 targets the murine renal collecting duct epithelium. Infect. Immun. 2009, 77:959-969.
46. Ren J., Utsunomiya I., Taguchi K., Ariga T., Tai T., Ihara Y., Miyatake T. Localization of verotoxin receptors in nervous system. Brain Res. 1999, 825:183-188.
47. Ridet J.L., Malhotra S.K., Privat A., Gage F.H. Reactive astrocytes: cellular and molecular clues to biological function. Trends Neurosci. 1997, 20:570-577.
48. Sakuma M., Hyakawa N., Kato H., Araki T. Time dependent changes of striatal interneurons after focal cerebral ischemia in rats. J. Neural Transm. 2008, 115:413-422.
49. Sánchez C., Díaz-Nido J., Avila J. Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function. Prog. Neurobiol. 2000, 61:133-168.
50. Sandvig K., van Deurs B. Delivery into cells: lessons learned from plant and bacterial toxins. Gene Ther. 2005, 12:865-872.
51. Scarlett J.M., Jobst E.E., Enriori P.J., Bowe D.D., Batra A.K., Grant W.F., Cowley M.A., Marks D.L. Regulation of central melanocortin signaling by interleukin-1 beta. Endocrinology 2007, 148:4217-4225.
52. Steinborn M., Leiz S., Rüdisser K., Griebel M., Harder T., Hahn H. CT and MRI in haemolytic uraemic syndrome with central nervous system involvement: distribution of lesions and prognostic value of imaging findings. Pediatr. Radiol. 2004, 34:805-810.
53. Stone M.K., Kolling G.L., Lindner M.H., Obrig T.G. p38 mitogen-activated protein kinase mediates lipopolysaccharide and tumor necrosis factor alpha induction of shiga toxin 2 sensitivity in human umbilical vein endothelial cells. Infect. Immun. 2008, 76:1115-1121.
54. Stricklett P.K., Hughes A.K., Ergonul Z., Kohan D.E. Molecular basis for up-regulation by inflammatory cytokines of Shiga toxin 1 cytotoxicity and globotriaosylceramide expression. J. Infect. Dis. 2002, 186:976-982.
55. Takahashi K., Funata N., Ikuta F., Sato S. Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2. J. Neuroinflammation 2008, 5:11. 10.1186/1742-2094-5-11.
56. Takenouchi H., Kiyokawa N., Taguchi T., Matsui J., Katagiri Y.U., Okita H., Okuda K., Fujimoto J. Shiga toxin binding to globotriaosyl ceramide induces intracellular signals that mediate cytoskeleton remodeling in human renal carcinoma-derived cells. J. Cell Sci. 2004, 117:3911-3922.
57. Valles P.G., Pesle S., Piovano L., Davila E., Peralta M., Principi I., Lo Giudice P. Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome similar to septic shock. Medicina 2005, 65:395-401.
58. Wang W., Svanberg E., Delbro D., Lundholm K. NOS isoenzyme content in brain nuclei as related to food intake in experimental cancer cachexia. Brain Res. Mol. Brain Res. 2005, 134:205-214.
59. Zhou Q., Zhang Q., Zhao X., Duan Y.Y., Lu Y., Li C., Li T. Cortical electrical stimulation alone enhances functional recovery and dendritic structures after focal cerebral ischemia in rats. Brain Res. 2010, 1311:148-157.